Categories: News

Cell Impact and thyssenkrupp Automation Engineering have entered a cooperation agreement

KARLSKOGA, Sweden, Nov. 6, 2025 /PRNewswire/ — Cell Impact and thyssenkrupp Automation Engineering have entered a Strategic Cooperation Agreement for Joint Market Success in the Field of Hydrogen. The agreement includes a shared ambition to carry out joint marketing activities as well as technical development of flow plates and manufacturing processes for fuel cells and electrolyzers.

- Advertisement -

 

- Advertisement -

thyssenkrupp Automation Engineering is a business unit of the automotive segment of the industrial group thyssenkrupp. With a focus on drive and battery assembly systems – particularly for electric mobility – the company offers high-quality, innovative automation solutions for series production. Around 1,100 employees work for Automation Engineering across ten countries on three continents.

- Advertisement -

“They have extensive experience in automation and industrialization, and are simply a highly suitable partner for us. Based on Cell Impact Forming™, our unique and patented forming technology, we can scale the business together with thyssenkrupp by developing, marketing, and supplying cost-effective and high-quality flow plates to customers worldwide,” says Daniel Vallin, CEO of Cell Impact.

- Advertisement -

During several years, Cell Impact has been developing forming technology and other process steps to enable industrial-scale production of flow plates once market demand is established.

- Advertisement -

The company has already manufactured and delivered several million flow plates to customers in Asia, North America, and Europe.

- Advertisement -

The cooperation agreement builds on a Letter of Intent (LOI) that the parties agreed upon in July 2025.

- Advertisement -

For more information, please contact:

Daniel Vallin
CEO and IR contact, Cell Impact AB (publ)
+46730686620 or daniel.vallin@cellimpact.com

- Advertisement -

About Cell Impact
Cell Impact AB (publ) is a global supplier of advanced flow plates to fuel cell and electrolyzer manufacturers. The company has developed and patented a unique method for high velocity forming, Cell Impact Forming™ which is significantly more scalable and cost-efficient compared to conventional forming methods. Cell Impact Forming is an environmentally friendly forming technology that consumes no water and very little electrical power.

- Advertisement -

The Cell Impact share is listed on Nasdaq First North Growth Market and FNCA Sweden AB is the company’s Certified Advisor (CA).

- Advertisement -

Photo: https://mma.prnewswire.com/media/2816029/Cell_Impact_Forming.jpg
Logo: https://mma.prnewswire.com/media/2816030/Cell_Impact_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/cell-impact-and-thyssenkrupp-automation-engineering-have-entered-a-cooperation-agreement-302607577.html

- Advertisement -

Recent Posts

Charles Winslow Completes Annual Internal Strategic Review at Lumena Intelligent Alliance Office

Jersey City, NJ, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Lumena Intelligent Alliance Office confirmed that…

5 hours ago

DebitMyData Human Energy Grid: The Trillion-Dollar Infrastructure Play That Genesis Executive Order Validates

DebitMyData™ Logo FORT LAUDERDALE, Fla., Dec. 25, 2025 (GLOBE NEWSWIRE) -- DebitMyData, Inc., having oversubscribed…

5 hours ago

Yoolax Announces a Milestone 2025 of Growth, Smart Innovation, and Customer Trust

HongKong, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Yoolax, a leading brand in the motorized window…

5 hours ago

Profound Medical Corp. Announces Upsize of Private Placement

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the…

8 hours ago

ImmuCell Announces Strategic Focus on First Defense After Receiving an FDA Incomplete Letter for Re-Tain

December 24, 2025 13:05 ET  | Source: ImmuCell Corporation PORTLAND, Maine, Dec. 24, 2025 (GLOBE…

8 hours ago

WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025

Hangzhou, China, Dec. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK)…

8 hours ago